Cell Reprogramming in Hematopoiesis and Immunity. @LuWcmm @Lund_Stem @lunduniversity. Tweets by Filipe Pereira (signed FP) and Malavika Nair (for CFP lab).
Joined June 2016
- Tweets 590
- Following 1,406
- Followers 2,323
- Likes 819
209 Photos and videos
May 17
Last chance to apply for the DDLS PhD student positions! šØ
Deadline is today. Donāt miss the opportunity!
#PhD #DDLS
Apr 17
1/4 We are recruiting! Our lab was awarded a PhD grant from @scilifelab Data-driven Life Science (DDLS) Research School for the project āA virtual cellular reprogramming screening platformā.
#DataDrivenLifeScience #CellReprogramming
5
4
2,926
May 7
1/4 Our new protocol paper is out in STAR Protocols!šāØ
We outline how to identify transcription factor (TFs) networks for immune cell reprogramming.
Read full paper here: cell.com/star-protocols/fullā¦
1
19
101
7,452
May 7
3/4 The workflow includes lentiviral production, arrayed library transduction, reprogramming, cell purification, library preparation, sequencing, a downstream analysis pipeline, with quality control and troubleshooting guidance throughout.
1
216
May 7
4/4 āļøThe framework is broadly adaptable, making it applicable across reprogramming systems and boosting accessibility to everyone aiming to seize the potential of direct reprogramming to generate therapeutic cell types.
130
Apr 30
1/2 If you didnāt have an exciting scientific event planned for the Fall, you do now! We are thrilled to announce the Immunity by Design: In VivoImmune Cell Engineering Conference, taking place in Lund 22-23 October 2026.
#ImmuneEngineering #Immunotherapy #BiotechIndustry
1
1
8
484
Apr 30
2/2 This event will bring together scientists, clinicians, & biotech leaders to discuss present & future of immune engineering & immunotherapy. The expanding field of in vivo cell engineering will have a special focus. Save the date & join us!
More info: immunitybydesign.se/
1
87
Apr 27
š¬ Lund University is hiring 3 Assistant Professors in cancer immunotherapy, immunotechnology & immune cell engineering!
ā
Start-up package | tenure track | world-class infrastructure
š
Deadlines: 26 May & 10 June 2026
š„youtu.be/z-PQU9qknZc
Apply links š
1
5
7
1,113
Apr 27
Position 3:
Immunotechnology with focus on Cancer Immunotherapy - bridging cutting-edge antibody technology and cellular therapies at the Department of Immunotechnology (LTH), within the L2CancerBridge programme.
š Apply: lu.varbi.com/en/what:job/jobā¦
1
77
Apr 21
1/1 We are recruiting anĀ Assistant Professor in Immuno-oncology and Immune Cell Engineering to join the newly established Division of Immuno-Oncology atĀ Lund University!
1
5
24
1,918
Apr 21
2/3 Join us if you have a strong track record & are ready to build your own research programme in areas like:
ā In vivo immune engineering
ā Next-gen cell & gene therapies (CAR-T, CAR-NK)
ā Synthetic immunology & CRISPR/TF screening
ā Delivery systems for in situ cell engineering
1
164
Apr 21
3/3 Tenure-track position with a clear path to promotion and a substantial start-up package.Ā
Apply by 10 June 2026.Ā
Details here: lu.varbi.com/en/what:job/jobā¦Ā
Know someone who fits? Please share with your network!āØ
143
Apr 17
1/4 We are recruiting! Our lab was awarded a PhD grant from @scilifelab Data-driven Life Science (DDLS) Research School for the project āA virtual cellular reprogramming screening platformā.
#DataDrivenLifeScience #CellReprogramming
2
4
18
4,762
Apr 17
3/4 Within the DDLS Research School, the recruited PhD student will analyze highly multiplexed REPROcode datasets with mathematical modelling to reveal transcription factors combinations that drive immune cell identity.
1
2
308
Apr 17
4/4 We greatly appreciate SciLifeLabās support in advancing computational immune reprogramming! If youāre excited about computational biology, singleācell data, and modelling immune cell identity, this is a fantastic opportunity to join us.
Apply here: lu.varbi.com/en/what:job/jobā¦
1
2
229
Apr 13
1/3 Huge congrats to our team member Sandhya Malla @mal71056, who was awarded a Postdoctoral Fellowship by @Cancerfonden with her project āDecoding The Regulatory Grammar of Transcription Factor-Mediated Immune Reprogrammingā!
1
7
461
Apr 13
2/3 Despite the therapeutic promise of tumor-to-dendritic cell reprogramming by PU.1, IRF8 and BATF3 (PIB) overexpression, reprogramming efficiency is variable across tumors. Sandhya will address this by decoding the nucleosomal structure and temporal dynamics of PIB activity.
1
137
Apr 13
3/3 This work will define the structural and temporal barriers that are limiting PIB reprogramming efficiency to enable efficacy across tumors and successful clinical translation. Bravo Sandhya!
For more info see: pereiralab.com/lab-news/sandā¦
1
149